Evidence map›Paper›PMID 36813827›Full record

ArticleNPJ digital medicine2023

Author Correction: Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials.

Andre Esteva, Jean Feng, Douwe van der Wal, Shih-Cheng Huang, Jeffry P Simko, Sandy DeVries, Emmalyn Chen, Edward M Schaeffer, Todd M Morgan, Yilun Sun and 23 more

Registry-linked trialAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in NPJ digital medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06772441 (Prostate-only, Dose-escalated Radiotherapy Plus Concomitant Androgen Deprivation Therapy in Primary Localized, NCCN High Risk and MMAI Classifier Low or Intermediate-risk Prostate Cancer - a Prospective, Single-arm, Phase II Study), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06772441 phase2recruitingnot on this mapstarted 2024, after this paper: background citation

Prostate-only, Dose-escalated Radiotherapy Plus Concomitant Androgen Deprivation Therapy in Primary Localized, NCCN High Risk and MMAI Classifier Low or Intermediate-risk Prostate Cancer - a Prospective, Single-arm, Phase II Study

TypeinterventionalSponsorGerman Oncology Center, CyprusRan2024 to 2027Enrolled30ConditionsProstate CancerArmsAndrogen deprivation therapy (ADT)
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

33 authors.

Andre EstevaArtera, Inc, Mountain View, CA, USA. aesteva@artera.ai.
Jean FengDepartment of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0003-2041-3104
Douwe van der WalArtera, Inc, Mountain View, CA, USA.
Shih-Cheng HuangDepartment of Biomedical Data Science, Stanford University, Stanford, CA, USA.
Jeffry P SimkoDepartment of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
Sandy DeVriesNRG Oncology Biospecimen Bank, San Francisco, CA, USA.
Emmalyn ChenArtera, Inc, Mountain View, CA, USA.
Edward M SchaefferDepartment of Urology, Northwestern University, Evanston, IL, USA.
Todd M MorganDivision of Urologic Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0002-1140-0603
Yilun SunDepartment of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA.ORCID http://orcid.org/0000-0002-1341-382X
Amirata GhorbaniSalesforce Research, San Francisco, CA, USA.
Nikhil NaikSalesforce Research, San Francisco, CA, USA.
Dhruv NathawaniSalesforce Research, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-0296-8408
Richard SocherSalesforce Research, San Francisco, CA, USA.
Jeff M MichalskiDepartment of Radiation Oncology, Washington University School of Medicine, Saint Louis, MO, USA.
Mack RoachDepartment of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
Thomas M PisanskyDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Jedidiah M MonsonDepartment of Radiation Oncology, cCare, Fresno, CA, USA.
Farah NazDepartment of Radiation Oncology, Horizon Health Network-Saint John Regional Hospital, Saint John, JB E2L 4L2, CA, Canada.
James WallaceDepartment of Hematology and Oncology, Ingalls Memorial Hospital, Harvey, IL, USA.
Michelle J FergusonDepartment of Radiation Oncology, Allan Blair Cancer Centre, Regina, SK S4T 7T1, CA, Canada.
Jean-Paul BaharyDepartment of Radiation Oncology, CHUM - Centre Hospitalier de l'Universite de Montreal, Montreal, QC H2X 3E4, CA, Canada.
James ZouDepartment of Biomedical Data Science, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0001-8880-4764
Matthew LungrenDepartment of Biomedical Data Science, Stanford University, Stanford, CA, USA.
Serena YeungDepartment of Biomedical Data Science, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0003-0529-0628
Ashley E RossDepartment of Urology, Northwestern University, Evanston, IL, USA.
NRG Prostate Cancer AI Consortium
Howard M SandlerDepartment of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0002-8193-5769
Phuoc T TranDepartment of Radiation Oncology, University of Maryland, Baltimore, MD, USA.
Daniel E SprattDepartment of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA.
Stephanie PughNRG Oncology Statistics and Data Management Center, Philadelphia, PA, USA.
Felix Y Feng *Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
Osama Mohamad *Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36813827
PMCPMC9947124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.